Skip to Main Content
About
Pipeline
Platform
Investors
Careers
Our Team
Partnering
News & Events
Contact Us
ABCL635
ABCL575
Targets and Modalities
Publications
Current Openings
Partnering
News & Events
Contact Us
Clinical Trials
Publications
Current Openings
About
Our Team
Partnering
News & Events
Contact Us
Pipeline
ABCL635
ABCL575
Platform
Targets and Modalities
Publications
Investors
Careers
Current Openings
604.559.9005
Get in touch
News & events.
Our news.
Filter by Category
Filter by Category
News
Event
Text Link
Filter by Year
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Link 1
Filter by Category
News
Event
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
October 11, 2022
2022
AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022
Read article
News
October 5, 2022
2022
AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022
Read article
Event
October 5, 2022
2022
SITC Annual Meeting 2022
Read article
Event
August 24, 2022
2022
BIO-Europe 2022
Read article
Event
August 24, 2022
2022
BioProcess International 2022
Read article
Event
August 10, 2022
2022
Festival of Biologics EU 2022
Read article
News
August 3, 2022
2022
AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients
Read article
News
July 27, 2022
2022
Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies
Read article
News
July 12, 2022
2022
AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022
Read article
News
June 30, 2022
2022
Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options
Read article
1